Business Wire

HD-PLC Alliance Develops Its Global Activities in High-speed Power Line Communications and High-speed Wired Communications

Share

Last year, HD-PLC Alliance *1, Fukuoka, Japan (Alliance) launched the “Global Strategy Preparatory Office”, a new ad-hoc working group, to support the advancement of IoT migration which is leading to a dramatic growth of the needs for high-speed PLC in various systems such as smart-meter, factory-automation (FA), building-automation (BA), solar power generation, smart-streetlight, smarter-city, smarter-home, etc.

The Alliance announces today several initiatives as part of the development of its global activities.

First, the Alliance will hold an HD-PLC *2 global web seminar (webinar) jointly with IEEE SA*3 on coming Thursday, 18th March to showcase its ecosystem footprint.

  • Event title: [IEEE SA And HD-PLC Alliance Webinar March 2021]
    Home Networking, Industrial and Building Automation through HD-PLC (High Speed Powerline Communication)
  • Topics covered/Agenda: HD-PLC technology and Standards, Building Automation, Industrial Case Studies, In-home systems, Internet of Things (IoT), HD-PLC licensing program
  • Presenter: IEEE 1901 Working Group Chair, Panasonic, MegaChips, Alliance Chair and Manager

The official website has been completely renewed in February this year and the Alliance has increased its presence on the SNS site such as Facebook, LinkedIn to disseminate more information globally.

The Alliance will actively contribute to the activities of global standardization in cooperation with IEEE despite of COVID-19 disaster these days.

Since its establishment in 2007, the Alliance has carried out global activities in Europe, U.S.A, Asia to expand and spread HD-PLC and to ensure interoperability. As a result, the global IEEE Standard 1901*4 was approved in 2010, adopting HD-PLC as core technology. "The IEEE 1901 standard is the FIRST standard that converted scattered initiatives into a profitable industry offering assurance of interoperability to users” said Jean-Philippe Faure, IEEE 1901 Working Group Chair.

In 2012 the HD-PLC technology was adopted in the Chinese national standard GB/T 29265.305-2012 *5. Additionally, U.S. standard ANSI/CTA 709.8 LON HD-PLC*6, based on IEEE std 1901, has been approved in 2020. This shows that HD-PLC is broadly recognized as one of most popular global High-speed Power Line Communication standard.

The Alliance has continuously contributed and will continue to contribute to the evolution of the IEEE 1901 standard. "The continuous development of amendments within the IEEE 1901 Working Group consolidates the technology, inspires new uses in new sectors - LON standard - and expands the PLC market to new generations of products.” continued Jean-Philippe Faure. The last achievement was the publication of IEEE Std 1901-2020.

Note:

  1. The unincorporated association founded by Panasonic Corporation in 2017, which aims to expand and increase the use of HD-PLC and ensure interoperability between equipment with built-in HD-PLC.
  2. An abbreviation for “High Definition Power Line Communication” originally. HD-PLC™ or HD-PLC™ mark is a registered trademark or trademark of Panasonic Corporation in Japan and in other countries.
  3. The IEEE (Institute of Electrical and Electronics Engineers, U.S.A) Standards Association.
  4. The global standard on high-speed Power Line Communication that adopted HD-PLC as core technology in 2010. The latest revision, IEEE 1901 std-2020, has been published in January 2021.
    https://standards.ieee.org/standard/1901-2020.html
  5. IGRS (a communication industry organization in China), the Alliance, Panasonic, etc. worked for this standardization together. It was approved in 2012.
  6. American National Standards Institute (ANSI) approved as American National Standard (ANS).

Contact information

HD-PLC Alliance
Takanori Miyake, Ryoji Kido,
E-mail: info@hd-plc.org

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

University of Siena Researchers Demonstrate Rapid UV Disinfection of Operating Rooms Between Surgeries14.4.2021 15:00:00 EEST | Press release

UltraViolet Devices, Inc. (UVDI), a global leader in Ultraviolet Air and Surface disinfection, announced new research demonstrating the UVDI-360 Room Sanitizer’s rapid disinfection of operating rooms between surgical procedures will be presented at the Society for Healthcare Epidemiology of America (SHEA) Spring Conference, taking place April 13-16, 2021. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210414005184/en/ In the University of Siena research, the UVDI-360 Room Sanitizer effectively inactivated germs in operating rooms in six minutes. (Photo: Business Wire) In the research, conducted by Dr. Gabriele Messina, Professor of Public Health, University of Siena at the Rugani Hospital Monteriggioni in Siena, the UVDI-360 Room Sanitizer achieved a greater than 97% germ reduction in operating rooms in only six minutes, with two three-minute disinfection cycles run on each side of the operating table. Testing the UVDI-360 R

Amylyx Pharmaceuticals Provides Global Regulatory Update on AMX0035 for ALS14.4.2021 15:00:00 EEST | Press release

Amylyx Pharmaceuticals, Inc., a pharmaceutical company focused on developing new treatments for amyotrophic lateral sclerosis (ALS), Alzheimer’s Disease and other neurodegenerative diseases, today provided an update on its plans to advance AMX0035 through the clinical development process for the treatment of ALS. The company intends to submit a Marketing Authorization Application (MAA) for AMX0035 to the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) by the end of 2021. As previously reported, the company plans to submit a marketing application with Health Canada Q2 2021. The FDA has expressed an interest in seeing data from an additional placebo-controlled clinical trial prior to receiving a New Drug Application (NDA), the vehicle through which a pharmaceutical sponsor formally proposes that the FDA approve an investigational product. To fulfill the FDA’s request and to continue to build upon the growing body of evidence supporting AMX0035 for

Noxopharm Files Septic Shock Treatment Patent for Veyonda®14.4.2021 15:00:00 EEST | Press release

Australian clinical-stage drug development company Noxopharm Limited (ASX:NOX) announced an international patent application aimed at protecting the use of experimental anti-cancer drug, Veyonda® (idronoxil), in blocking the development of septic shock associated with infections such as COVID-19 and influenza viruses. Overall, septic shock is believed responsible for an estimated 10 million global deaths per year, with an estimated three million additional deaths due to the current pandemic. So-called ‘long COVID’ symptoms (e.g., long-lasting fatigue, breathing problems, headaches), along with severe organ damage (e.g., limb amputation, diabetes, kidney, and heart failure) and death are all are outcomes associated with septic shock. Veyonda is being developed as an anti-cancer drug based on immunostimulation and anti-inflammation functions. Its anti-inflammatory action stems from blocking of a signalling pathway called STING that normally serves as trigger for an inflammatory response

HTL Biotechnology and Echelon Biosciences Inc. announce strategic partnership to advance biopolymer platform and hyaluronic acid research tools14.4.2021 13:00:00 EEST | Press release

HTL, the worldwide leader in biotechnology solutions using hyaluronic acid (HA) and other biopolymers, and Echelon Biosciences Inc., a U.S.-based global supplier of biochemical reagents, assays, and services to research and development laboratories, announced today their new distribution and product development partnership. The partnership will enable distribution of high-quality HA and glycosaminoglycan (GAG), and the co-development of novel GAG products. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210414005119/en/ HTL's campus is located in Paris, France. HTL, the worldwide leader in biotechnology solutions using hyaluronic acid (HA) and other biopolymers, and Echelon Biosciences Inc., a U.S.-based global supplier of biochemical reagents, assays, and services to research and development laboratories, announced today their new distribution and product development partnership. The partnership will enable distribution of h

Eckert & Ziegler to Build cGMP Facility for Radiopharmaceutical Services in Berlin14.4.2021 12:59:00 EEST | Press release

Eckert & Ziegler is proud to announce that it is expanding its production site in Berlin, Germany, with a new production facility for the contract manufacturing of radiopharmaceuticals. This new cGMP clean room suite with a total area of around 270 m² will be a 21 CFR 211 compliant, radiopharmaceutical manufacturing facility dedicated to late stage investigational and commercial stage radiopharmaceuticals and be operational from the first quarter of 2022. Together with a new U.S. based cGMP facility, Eckert & Ziegler will be able to provide radiopharmaceutical development services to companies looking for Europe, US and worldwide contract manufacturing. “We have decided to make this investment to meet the growing global demand for radiopharmaceutical services in both imaging and therapy products. At the moment, a large number of radiopharmaceutical substances from international pharmaceutical companies are in advanced clinical trials, some of them for broad indications such as prostate

VertiGIS Acquires Facility Management Software Partner KMS14.4.2021 12:00:00 EEST | Press release

VertiGIS, a leading geographic information systems (GIS) solution provider and software developer, announced today the completed acquisition of longstanding development partner KMS Computer GmbH. KMS is an established and trusted computer-aided facility management (CAFM) software specialist based in Dresden, Germany. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210414005039/en/ KMS by VertiGIS is an established and proven provider of computer-aided facility management (CAFM) software based in Dresden, Germany. KMS is known for its GEBman software and has been supporting municipalities, industrial, service and utility companies, among others, with their facility and document management requirements since 1990. The flexible, end-to-end solutions are based on the latest web technologies and are suitable for internal or mobile use. (Graphic: Business Wire) VertiGIS is backed by global, technology-based investment firm Battery

IDEMIA and INTERPOL Further Their Partnership to Supply Brand New Multi-Biometric System14.4.2021 11:24:00 EEST | Press release

Following the renewal of an existing contract, IDEMIA will deliver INTERPOL’s new identification system that will usher in enhanced capabilities such as higher matching accuracy and more user-friendly interfaces. Designed and scaled so that police officers in member states can carry out an unlimited number of searches and analysis at will, MBIS, IDEMIA’s latest technological biometric solution, will allow up to one million forensic analysis searches per day. This includes fingerprints, palm prints and faces, making it the top performing automated biometric identification system on the market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210414005324/en/ (Photo: Business Wire) These capabilities pave the way for introducing the application of biometrics to other sectors. In addition to police investigations, INTERPOL plans to enable its members to query their database from border control stations. This latest alliance furth

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom